- What are the advanced breast cancer screening test available in India? Are there any tests that are being utilized at the hospital?
In India, advanced breast cancer screening tests include digital mammography, 3D tomosynthesis, breast MRI, and ultrasound, which help detect cancer early and provide detailed images of breast tissue. Genetic testing for BRCA1 and BRCA2 mutations is also available for people with a strong family history of breast cancer. Some hospitals use molecular tests and gene panels to assess cancer risk or guide treatment. At larger hospitals and cancer centres, tests like contrast-enhanced mammography and PET-CT scans are sometimes used for high-risk patients or to detect cancer spread. Hospitals also offer image-guided biopsy techniques to confirm diagnosis quickly and accurately. Many hospitals in India combine these advanced imaging tests with routine screenings to provide a comprehensive approach, ensuring early detection, personalized treatment plans, and better outcomes for patients. These advanced tests are gradually becoming more common in private and specialized healthcare centres. - Is AI or data analytics also being used for such tests?
Yes, AI and data analytics are increasingly being used in breast cancer screening in India. Artificial intelligence can help doctors analyze mammograms, 3D tomosynthesis, and MRI images more quickly and accurately by detecting patterns that may be missed by the human eye. AI systems can highlight suspicious areas, reduce false positives, and assist in early diagnosis. Data analytics is used to track patient history, risk factors, and screening results over time, helping doctors make better decisions about follow-up tests or treatments. Some hospitals also use AI to predict the likelihood of cancer spreading or recurring, which supports personalized treatment plans. These technologies are being integrated into advanced imaging machines and hospital software systems, improving efficiency and accuracy. While AI is not yet a replacement for doctors, it acts as a powerful tool alongside traditional and advanced screening tests, helping doctors provide faster, more precise, and more informed care to patients. - Can women younger than 45-50 years old take such tests as well?
Yes, women younger than 45–50 years old can take advanced breast cancer screening tests, especially if they have risk factors. Women with a strong family history of breast cancer, or other risk factors may be advised to start screening earlier. In such cases, doctors may recommend breast MRI, ultrasound, or genetic testing in addition to regular mammograms, because younger women often have denser breast tissue that can make traditional mammograms less effective. Some hospitals also offer personalized screening plans using AI and data analytics to determine the best age and type of test for each woman. Early screening in younger women helps detect cancer at an early stage, improving treatment outcomes. However, doctors usually evaluate the benefits and risks before recommending advanced tests, as unnecessary imaging may cause anxiety or false positives. Personalized guidance is key for women under 45. - What are the key factors that women need to keep in mind while taking such tests?
While taking advanced breast cancer screening tests, women need to keep several key factors in mind. First, they should know their personal and family history of breast cancer, as this affects which tests are most suitable. Age, breast density, and overall health are also important in deciding the type and frequency of screening. Women should discuss the benefits and limitations of each test with their doctor, including the possibility of false positives or unnecessary follow-ups. Timing of the test is important; for example, mammograms are usually done when breasts are least tender. Women should also inform the doctor about any implants, previous surgeries, or medications, as these can affect results. Understanding costs, insurance coverage, and availability of tests in their hospital is important. Finally, women should follow up on results promptly and maintain regular screenings, even if no cancer is detected, to ensure early detection and better outcomes.
Head of Department for Breast Oncology and Oncoplasty, Aster International Institute of Oncology, Aster CMI Hospital